1. Home
  2. NTES vs VRTX Comparison

NTES vs VRTX Comparison

Compare NTES & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTES
  • VRTX
  • Stock Information
  • Founded
  • NTES 1997
  • VRTX 1989
  • Country
  • NTES China
  • VRTX United States
  • Employees
  • NTES N/A
  • VRTX N/A
  • Industry
  • NTES Computer Software: Prepackaged Software
  • VRTX EDP Services
  • Sector
  • NTES Technology
  • VRTX Technology
  • Exchange
  • NTES Nasdaq
  • VRTX Nasdaq
  • Market Cap
  • NTES 95.1B
  • VRTX 96.6B
  • IPO Year
  • NTES 2000
  • VRTX 1991
  • Fundamental
  • Price
  • NTES $148.26
  • VRTX $417.74
  • Analyst Decision
  • NTES Strong Buy
  • VRTX Buy
  • Analyst Count
  • NTES 6
  • VRTX 26
  • Target Price
  • NTES $129.83
  • VRTX $491.78
  • AVG Volume (30 Days)
  • NTES 634.0K
  • VRTX 1.5M
  • Earning Date
  • NTES 11-13-2025
  • VRTX 11-03-2025
  • Dividend Yield
  • NTES 1.95%
  • VRTX N/A
  • EPS Growth
  • NTES 19.96
  • VRTX N/A
  • EPS
  • NTES 1.49
  • VRTX 14.07
  • Revenue
  • NTES $15,310,016,889.00
  • VRTX $11,418,800,000.00
  • Revenue This Year
  • NTES $11.57
  • VRTX $10.92
  • Revenue Next Year
  • NTES $7.58
  • VRTX $9.55
  • P/E Ratio
  • NTES $19.11
  • VRTX $29.62
  • Revenue Growth
  • NTES 2.75
  • VRTX 10.46
  • 52 Week Low
  • NTES $75.88
  • VRTX $362.50
  • 52 Week High
  • NTES $159.55
  • VRTX $519.88
  • Technical
  • Relative Strength Index (RSI)
  • NTES 50.09
  • VRTX 60.33
  • Support Level
  • NTES $145.87
  • VRTX $405.54
  • Resistance Level
  • NTES $150.77
  • VRTX $415.55
  • Average True Range (ATR)
  • NTES 3.00
  • VRTX 9.38
  • MACD
  • NTES -0.93
  • VRTX 1.59
  • Stochastic Oscillator
  • NTES 27.48
  • VRTX 86.47

About NTES NetEase Inc.

Founded in the late 1990s as an internet portal, NetEase has transformed into a leading force in the second-largest online game company gaming in China. While its initial success was built upon the massively multiplayer online role-playing game Fantasy Westward Journey, NetEase has expanded its portfolio with captivating franchises that resonate with both domestic and international players. Over the past decade, the company has created titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which maintain significant player bases today. Beyond in-house development, the company also collaborates with likes of Microsoft and Marvel to create and publish games based on renowned IPs, including World of Warcraft, Diablo Immortal, and Marvel Rivals.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: